[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 24,549
Citations 0
Clinical Trials Update
December 24/31, 2019

Tranexamic Acid Improves Outcomes in TBI

JAMA. 2019;322(24):2375. doi:10.1001/jama.2019.20077

Tranexamic acid reduces the risk of death from mild to moderate traumatic brain injury (TBI) when treatment is delivered within 3 hours, according to a trial in the Lancet.

The study randomized 12 737 patients with TBI to receive tranexamic acid (loading dose 1 g over 10 minutes then infusion of 1 g over 8 hours) or placebo. About 72% of patients were treated within 3 hours of injury.